The State of Mexico is making a historic purchase of Medical Marijuana, Inc.’s HempMeds Mexico products for its citizens, starting with 11 epilepsy and cancer patients. Real Scientific Hemp Oil-X™ (RSHO-X™) is cannabinoid hemp oil with zero THC.
This is the first time a government in Mexico has purchased CBD products for its citizens. The Mexican government’s move would be similar to Medicaid covering medical cannabis here in the states, and is a huge development in medical cannabis history. A report published in Health Affairs found that if all American states had legalized medical marijuana in 2014, Medicaid could have saved $1 billion in spending on prescriptions.
To mark the announcement, State of Mexico Governor Eruviel Avila distributed HempMeds Mexico’s flagship product Real Scientific Hemp Oil-X™ to the first 11 epilepsy and cancer patients at the inauguration of a new hospital in the State of Mexico on Thursday, August 17, 2017.
Numerous patients with neurological diseases, lung disease, epilepsy and other health problems have reported that they use fewer prescription medicines and have seen remarkable progress after using HempMeds products.
Nearly half of cannabidiol patients stop using traditional medicines according to a recent report on CBD oil user experience by Brightfield Group and HelloMD, who anticipate that the total cannabidiol market will reach $467 million in 2017.
Dr. Saul Garza Morales, pediatric researcher and neurologist in Mexico, recently shared the positive results of a recent study he conducted on the effects of Medical Marijuana, RSHO-X™ product in treating children with severe epilepsy, in which 86 percent of the 29 patients he studied experienced statistically significant (greater than 50%) reduction in motor seizures. Seventeen percent of the children were fully seizure free for a 4-month period.
HempMeds® Mexico is the first company to receive government import permits for a cannabis product via approval by the Mexican Health Department, COFEPRIS.
HempMeds made international news last month for opening its Monterrey, Mexico office, which serves as the hub for distribution of RSHO-X™ to Mexican distributors and patients.
Mexico legalized the cultivation, production, and use of cannabis products with less than one percent THC for medical use when President Pena Nieto signed a bill into law on June 19.
“We want to congratulate the State of Mexico’s government for this historic purchase of our CBD products to help relieve the suffering of its citizens,” said Medical Marijuana, Inc. Dr. Stuart Titus. “We are a Company of firsts and we are excited about this new historic milestone of being the first Company that a government has purchased our CBD products to benefit its citizens. The plethora of benefits of medical cannabis to treat several types of indications in undeniable and we are encouraged to see not only health professional, but also now governments, are becoming increasingly interested in how CBD hemp oil can help heal.”
Mexico represents a potential $1 to $2 billion cannabidiol (CBD) hemp oil market over the next ten years for Medical Marijuana, Inc, part of an anticipated upward global trend for the industry to reach $63.5 billion by 2024. The company plans to invest over three million dollars in scientific research, product development and educative programs for health professionals by 2019.